Biblio
Found 11 results
Author Keyword Title Type [ Year
Filters: Author is Rainer Kimmig [Clear All Filters]
“Incorporation of pazopanib in maintenance therapy of ovarian cancer.”, J Clin Oncol, vol. 32, no. 30, p. 3382, 2014.
, “The impact of dose intensity on the efficacy of gemcitabine plus carboplatin (GC) therapy for recurrent platinum-sensitive ovarian cancer (PSOC): A retrospective analysis of AGO-OVAR 2.5. ”, J Clin Oncol , vol. 29, no. suppl; abstr 5088, 2011.
, “Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.”, Ann Oncol, vol. 22, no. 11, p. 2423, 2011.
, “A phase 3 trial of bevacizumab in ovarian cancer.”, N Engl J Med, vol. 365, no. 26, p. 2496, 2011.
, “Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial. ”, J Clin Oncol, vol. 24, no. 7, pp. 1127-35, 2006.
, “Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG”, J Clin Oncol, vol. 24, pp. 4699-707, 2006.
, “Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.”, J Clin Oncol, vol. 24, no. 29, pp. 4699-707, 2006.
, “Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)”, Gynecol Oncol, vol. 100, pp. 300-7, 2006.
, “Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO”, J Natl Cancer Inst, vol. 98, pp. 1036-45, 2006.
“Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.”, J Natl Cancer Inst, vol. 98, no. 15, pp. 1036-45, 2006.
,